What’s new

• Promoter trust pledges 27.49% of Themis Medicare to back OSS Software debenture
• Pledge created in favour of CTL Trusteeship on June 29, 2026
• OSS Software Solutions Labs is the debenture issuer, not Themis Medicare

Why it matters

A promoter group pledging over a quarter of a listed company's equity to secure a debt of an unrelated entity is a clear governance red flag. It implies financial interlinking and potential liquidity stress within the promoter group. Under SEBI Takeover Code, such encumbrance is treated as an acquisition, making this a mandatory disclosure.

What we’re watching

• Details of the debenture amount and repayment terms
• Any clarification from Themis on the purpose and implications
• Share price reaction given the stock's high P/E of 920x

The full read

Themis Medicare's promoter group has pledged 27.49% of the company's equity (2,53,17,620 shares) to secure a debenture issued by OSS Software Solutions Labs, an entity unrelated to the drugmaker. The pledge was created on June 29, 2026. For a micro-cap with a market cap of ₹1,053 crore and a trailing P/E of 920x, this is an outsized encumbrance. It ties promoter wealth to an external entity's debt, raising governance flags. Under Takeover Code rules, the pledge itself is an acquisition event. The company's own financials (debt/equity of 0.21, profit growth of 125%) offer no comfort if the promoter's personal borrowing goes wrong.

Primary source: BSE · NSE